| PERIOD ENDING | 31-Dec-05 | 30-Sep-05 | 30-Jun-05 | 31-Mar-05 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 11,450 | (4,648) | 8,329 | 4,818 | | Selling General and Administrative | (6,542) | 12,375 | 2,972 | 2,382 | | Non Recurring | (299) | 288 | 818 | 32,992 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,608) | (8,016) | (12,119) | (40,192) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,731 | 116 | 276 | 244 | | Earnings Before Interest And Taxes | (2,878) | (7,900) | (11,843) | (39,948) | | Interest Expense | 493 | 831 | 871 | 723 | | Income Before Tax | (3,370) | (8,731) | (12,714) | (40,671) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,370) | (8,731) | (12,714) | (40,671) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,370) | (8,731) | (12,714) | (40,671) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,370) | ($8,731) | ($12,714) | ($40,671) |
|
0.83% Nasdaq 
Income Statement
